Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06968468 · ClinicalTrials.gov registry record · NA
Resiliency Intervention for Patients With ALS and Their Care-Partners
A NA study, sponsored by Massachusetts General Hospital.
- Not yet
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT06968468: Clinical Trial NA study, sponsored by Massachusetts General Hospital.
NCT06968468 is a NA study that has not yet begun recruiting, run by Massachusetts General Hospital. The registered enrollment target is 20 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06968468, a NA study, has not yet begun recruiting, sponsored by Massachusetts General Hospital.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
The purpose of this study is to pilot a resiliency and coping intervention for persons recently diagnosed with Amyotrophic Lateral Sclerosis (ALS) and their primary informal caregivers. The data investigators gather in this study will be used to further refine our intervention.
Interventions
- BEHAVIORAL Resilient Together ALS
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2026-05-13 |
| Est. Completion | 2027-02-28 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06968468
The ClinicalTrials.gov registry entry for NCT06968468 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Resilient Together ALS is the first listed.
NCT06968468 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06968468 about?
NCT06968468 is a clinical study titled "Resiliency Intervention for Patients With ALS and Their Care-Partners". The purpose of this study is to pilot a resiliency and coping intervention for persons recently diagnosed with Amyotrophic Lateral Sclerosis (ALS) and their primary informal caregivers. The data investigators gather in this study will be used to further refine our intervention.
What is the current status of trial NCT06968468?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2026-05-13. Estimated completion is 2027-02-28.
What interventions are being tested in trial NCT06968468?
The interventions under investigation include: Resilient Together ALS (BEHAVIORAL).
Who is sponsoring clinical trial NCT06968468?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.